Identifying New Aging and Longevity Genes in Caenorhabditis elegans

鉴定秀丽隐杆线虫新的衰老和长寿基因

基本信息

  • 批准号:
    7184344
  • 负责人:
  • 金额:
    $ 12.37万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-02-15 至 2008-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The candidate is an oncology fellow at the Dana-Farber Cancer Institute with prior research training as an MD-PhD student in mammalian apoptosis and immunology. He has returned to the laboratory after a 5 year hiatus spent pursuing clinical training, including internship and residency in Internal Medicine and subspecialty clinical training in Medical Oncology. He has developed an interest in aging and longevity and wishes to pursue a program of career development that will provide training in the areas of (1) biology of aging (2) functional genomics and (3) C. elegans as a model organism and tool. The career development plan calls for training under dual mentors Dr. Marc Vidal at Dana-Farber Cancer Institute, who is a pioneer in functional genomic approaches in C. elegans, as well as Dr. Gary Ruvkun at Massachusetts General Hospital, who is an established investigator in aging and longevity in C. elegans. In addition, there are many other institutions in the immediate vicinity that form a collectively very rich and diverse training environment. The research plan proposes to identify new aging and longevity genes in C. elegans by using a combined functional genomic approach. The known proteins involved in longevity in C. elegans, which comprise the daf-2 insulin-like signaling pathway, will be used as baits in genome-wide yeast two-hybrid screens (an approach termed protein interaction mapping). New interactors identified by these screens will be subject to a functional analysis that will initially consist of RNA-mediated interference (RNAi) to look at loss-of-function phenotypes. The phenotype to be initially examined is dauer formation, since historically mutations in genes in the daf-2 pathway that alter dauer formation also give longevity phenotypes. The dauer form is a dormant, hypoactive and long-lived larval form that can develop under harsh conditions, but that can resume normal development when conditions become more favorable. Preliminary data is presented identifying 7 novel interacting proteins, 2 of which give dauer phenotypes by RNAi. Longevity assays of candidate genes identified by two-hybrid are also proposed. It is anticipated that the combined approach of protein interaction mapping and RNAi-based analysis will identify many new genes involved in dauer formation, aging and longevity.
描述(由申请人提供):应聘者是Dana-Farber癌症研究所的肿瘤学研究员,曾接受过哺乳动物细胞凋亡和免疫学博士研究生的研究培训。在中断了5年的临床培训后,他回到了实验室,包括内科的实习和住院医生,以及内科肿瘤学的专科临床培训。他对衰老和长寿产生了兴趣,并希望从事一项职业发展计划,该计划将在(1)衰老生物学、(2)功能基因组学和(3)线虫作为模式生物和工具方面提供培训。职业发展计划要求在达纳-法伯癌症研究所的马克·维达尔博士和马萨诸塞州总医院的加里·鲁夫昆博士的双重指导下进行培训。维达尔博士是线虫功能基因组方法的先驱,加里·鲁夫昆博士是线虫衰老和寿命方面的知名研究员。此外,附近还有许多其他机构,形成了一个非常丰富和多样化的培训环境。该研究计划建议使用组合功能基因组学方法在线虫中识别新的衰老和长寿基因。线虫中与长寿有关的已知蛋白质,包括daf-2胰岛素样信号通路,将被用作全基因组酵母双杂交筛选的诱饵(一种被称为蛋白质相互作用图谱的方法)。通过这些筛选确定的新的相互作用因子将受到功能分析的影响,该分析最初将包括RNA介导的干扰(RNAi),以观察功能丧失的表型。最初要检查的表型是Dauer形成,因为在历史上,改变Dauer形成的daf-2途径中的基因突变也会产生长寿表型。达尔幼虫是一种休眠、不活跃、寿命长的幼虫,可以在恶劣的条件下发育,但当条件变得更有利时,可以恢复正常发育。初步鉴定了7个新的相互作用蛋白,其中2个通过RNAi给出了Dauer表型。还提出了双杂交确定的候选基因的寿命分析。预计蛋白质相互作用图谱和基于RNAi的分析相结合的方法将发现许多与Dauer形成、衰老和长寿有关的新基因。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MUNEESH TEWARI其他文献

MUNEESH TEWARI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MUNEESH TEWARI', 18)}}的其他基金

Highly specific, amplification-free, single-molecule counting of rare methylated DNA cancer biomarkers
对罕见甲基化 DNA 癌症生物标志物进行高度特异性、无扩增的单分子计数
  • 批准号:
    10025913
  • 财政年份:
    2020
  • 资助金额:
    $ 12.37万
  • 项目类别:
Clinical trial exploring the diet-microbiome axis in allo-HCT patients
探索异基因 HCT 患者饮食-微生物组轴的临床试验
  • 批准号:
    10441583
  • 财政年份:
    2020
  • 资助金额:
    $ 12.37万
  • 项目类别:
Clinical trial exploring the diet-microbiome axis in allo-HCT patients
探索异基因 HCT 患者饮食-微生物组轴的临床试验
  • 批准号:
    10650335
  • 财政年份:
    2020
  • 资助金额:
    $ 12.37万
  • 项目类别:
Clinical trial exploring the diet-microbiome axis in allo-HCT patients
探索异基因 HCT 患者饮食-微生物组轴的临床试验
  • 批准号:
    10241908
  • 财政年份:
    2020
  • 资助金额:
    $ 12.37万
  • 项目类别:
Optimization and Validation of Single-Molecule Kinetic Fingerprinting Technology for Rapid, Ultra-Specific Detection of Cancer Mutations
用于快速、超特异性检测癌症突变的单分子动力学指纹技术的优化和验证
  • 批准号:
    10000971
  • 财政年份:
    2018
  • 资助金额:
    $ 12.37万
  • 项目类别:
Reference Profiles of ExRNA in Biofluids from Well-Defined Human Cohorts
来自明确定义的人类群体的生物体液中 ExRNA 的参考图谱
  • 批准号:
    8774819
  • 财政年份:
    2014
  • 资助金额:
    $ 12.37万
  • 项目类别:
Reference Profiles of ExRNA in Biofluids from Well-Defined Human Cohorts
来自明确定义的人类群体的生物体液中 ExRNA 的参考图谱
  • 批准号:
    8900333
  • 财政年份:
    2014
  • 资助金额:
    $ 12.37万
  • 项目类别:
Reference Profiles of ExRNA in Biofluids from Well-Defined Human Cohorts
来自明确定义的人类群体的生物体液中 ExRNA 的参考图谱
  • 批准号:
    9125467
  • 财政年份:
    2014
  • 资助金额:
    $ 12.37万
  • 项目类别:
RNA as a Hormone: Systemic Signaling in Mammals via Circulating, Cell-Free Small
RNA 作为激素:哺乳动物中通过循环、无细胞小分子的系统信号传导
  • 批准号:
    7764065
  • 财政年份:
    2009
  • 资助金额:
    $ 12.37万
  • 项目类别:
RNA as a Hormone: Systemic Signaling in Mammals via Circulating, Cell-Free Small
RNA 作为激素:哺乳动物中通过循环、无细胞小分子的系统信号传导
  • 批准号:
    7937011
  • 财政年份:
    2009
  • 资助金额:
    $ 12.37万
  • 项目类别:

相似国自然基金

靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    0 万元
  • 项目类别:
    面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
  • 批准号:
    2023JJ50274
  • 批准年份:
    2023
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    33 万元
  • 项目类别:
    地区科学基金项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
  • 批准号:
    n/a
  • 批准年份:
    2022
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
  • 批准号:
    81973577
  • 批准年份:
    2019
  • 资助金额:
    55.0 万元
  • 项目类别:
    面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
  • 批准号:
    81602908
  • 批准年份:
    2016
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
  • 批准号:
    81501928
  • 批准年份:
    2015
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

The Phenomenon of Stem Cell Aging according to Methylation Estimates of Age After Hematopoietic Stem Cell Transplantation
根据造血干细胞移植后甲基化年龄估算干细胞衰老现象
  • 批准号:
    23K07844
  • 财政年份:
    2023
  • 资助金额:
    $ 12.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of Age-dependent Functional Changes in Skeletal Muscle CB1 Receptors by an in Vitro Model of Aging-related Muscle Atrophy
通过衰老相关性肌肉萎缩的体外模型分析骨骼肌 CB1 受体的年龄依赖性功能变化
  • 批准号:
    22KJ2960
  • 财政年份:
    2023
  • 资助金额:
    $ 12.37万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Joint U.S.-Japan Measures for Aging and Dementia Derived from the Prevention of Age-Related and Noise-induced Hearing Loss
美日针对预防与年龄相关和噪声引起的听力损失而导致的老龄化和痴呆症联合措施
  • 批准号:
    23KK0156
  • 财政年份:
    2023
  • 资助金额:
    $ 12.37万
  • 项目类别:
    Fund for the Promotion of Joint International Research (International Collaborative Research)
The Effects of Muscle Fatigability on Gait Instability in Aging and Age-Related Falls Risk
肌肉疲劳对衰老步态不稳定性和年龄相关跌倒风险的影响
  • 批准号:
    10677409
  • 财政年份:
    2023
  • 资助金额:
    $ 12.37万
  • 项目类别:
Characterizing gut physiology by age, frailty, and sex: assessing the role of the aging gut in "inflamm-aging"
按年龄、虚弱和性别表征肠道生理学特征:评估衰老肠道在“炎症衰老”中的作用
  • 批准号:
    497927
  • 财政年份:
    2023
  • 资助金额:
    $ 12.37万
  • 项目类别:
Role of AGE/RAGEsignaling as a driver of pathological aging in the brain
AGE/RAGE信号传导作为大脑病理性衰老驱动因素的作用
  • 批准号:
    10836835
  • 财政年份:
    2023
  • 资助金额:
    $ 12.37万
  • 项目类别:
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
  • 批准号:
    10679287
  • 财政年份:
    2023
  • 资助金额:
    $ 12.37万
  • 项目类别:
Elucidation of the protein kinase NLK-mediated aging mechanisms and treatment of age-related diseases
阐明蛋白激酶NLK介导的衰老机制及年龄相关疾病的治疗
  • 批准号:
    23K06378
  • 财政年份:
    2023
  • 资助金额:
    $ 12.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Underlying mechanisms of age-related changes in ingestive behaviors: From the perspective of the aging brain and deterioration of the gustatory system.
与年龄相关的摄入行为变化的潜在机制:从大脑老化和味觉系统退化的角度来看。
  • 批准号:
    23K10845
  • 财政年份:
    2023
  • 资助金额:
    $ 12.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Targeting Age-Activated Proinflammatory Chemokine Signaling by CCL2/11 to Enhance Skeletal Muscle Regeneration in Aging
通过 CCL2/11 靶向年龄激活的促炎趋化因子信号传导以增强衰老过程中的骨骼肌再生
  • 批准号:
    478877
  • 财政年份:
    2023
  • 资助金额:
    $ 12.37万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了